{"path":"Boxes/Temple College Nursing Program/LVN Program/Fall 24/Advanced Nursing Skills/Documents/Module I/Medication Dispensing Errors And Prevention - StatPearls - NCBI Bookshelf.pdf","text":"NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Medic a tio n D isp en sin g Erro rs A n d Preven tio n A utho rs Ra yha n A. Ta riq ; Rishik Va shisht; An kur Sin ha ; Yevgen iya Scherb a k. A ffilia tio n s Drexel Un iversity Co llege o f Medicin e Pa rkview Regio n a l Medica l Cen ter La st Up da te: July 3 , 2 0 2 2 . C o n tin uin g Educ a tio n A c tivity Clo se to 6 ,8 0 0 p rescrip tio n medicatio n s an d co un tless o ver-the-co un ter drugs are available in the Un ited States. To further co mp licate a p ractitio n er's resp o n sibility durin g p atien t care, there are tho usan ds o f health sup p lemen ts, herbs, p o tio n s, an d lo tio n s used by the p ublic regularly to treat their health p ro blems. With the n umber o f substan ces o n the market, it is co n ceivable that mistakes can be made when p ractitio n ers p rescribe o r disp en se drugs. Added to this is the high risk o f in teractio n between substan ces. Each year, in the Un ited States alo n e, 7 ,0 0 0 to 9 ,0 0 0 p eo p le die as a result o f a medicatio n erro r. Additio n ally, hun dreds o f tho usan ds o f o ther p atien ts exp erien ce but o ften do n o t rep o rt an adverse reactio n o r o ther medicatio n co mp licatio n s. The to tal co st o f lo o kin g after p atien ts with medicatio n - asso ciated erro rs exceeds $4 0 billio n each year. In additio n to the mo n etary co st, p atien ts exp erien ce p sycho lo gical an d p hysical p ain an d sufferin g as a result o f medicatio n erro rs. Fin ally, a majo r co n seq uen ce o f medicatio n erro rs is that it leads to decreased p atien t satisfactio n an d a gro win g lack o f trust in the healthcare system. This activity reviews the co mmo n causes o f medicatio n erro rs an d discusses the in terp ro fessio n al team's ro le in takin g step s to min imiz e medicatio n erro rs. Objectives: Iden tify the mo st co mmo n erro rs related to medicatio n s. Review so me o f the critical p o in ts at which medicatio n erro rs are mo st likely to o ccur. Outlin e so me strategies to p reven t medicatio n erro rs fro m o ccurrin g. Summariz e in terp ro fessio n al team strategies fo r decreasin g medicatio n erro rs. Access free multip le cho ice q uestio n s o n this to p ic. In tro duc tio n Clo se to 6 ,8 0 0 p rescrip tio n medicatio n s an d co un tless o ver-the-co un ter drugs are available in the Un ited States. To further co mp licate a p ractitio n er's resp o n sibility durin g p atien t care, there are tho usan ds o f health sup p lemen ts, herbs, p o tio n s, an d lo tio n s used by the p ublic regularly to treat their health p ro blems. With the n umber o f substan ces o n the market, it is co n ceivable that mistakes can be made when p ractitio n ers p rescribe o r disp en se drugs. Added to this is the high risk o f in teractio n between substan ces. Each year, in the Un ited States alo n e, 7 ,0 0 0 to 9 ,0 0 0 p eo p le die due to a medicatio n erro r. Additio n ally, hun dreds o f tho usan ds o f o ther p atien ts exp erien ce but o ften do n o t rep o rt an adverse reactio n o r o ther co mp licatio n s related to a medicatio n . The to tal co st o f lo o kin g after p atien ts with medicatio n -asso ciated erro rs exceeds $4 0 billio n each year, with o ver 7 millio n p atien ts affected. In additio n to the mo n etary co st, p atien ts exp erien ce p sycho lo gical an d p hysical 1 2 1 2 p ain an d sufferin g as a result o f medicatio n erro rs. Fin ally, a majo r co n seq uen ce o f medicatio n erro rs is that it leads to decreased p atien t satisfactio n an d a gro win g lack o f trust in the healthcare system.[1 ][2 ] The mo st co mmo n reaso n s fo r erro rs in clude failure to co mmun icate drug o rders, illegible han dwritin g, wro n g drug selectio n cho sen fro m a dro p -do wn men u, co n fusio n o ver similarly n amed drugs, co n fusio n o ver similar p ackagin g between p ro ducts, o r erro rs in vo lvin g do sin g un its o r weight. Medicatio n erro rs may be due to human erro rs, but it o ften results fro m a flawed system with in adeq uate backup to detect mistakes.[3 ][4 ] Definitions Medication Error While there is n o un ifo rm defin itio n o f a medicatio n erro r, The Natio n al Co o rdin atin g Co un cil fo r Medicatio n Erro r Rep o rtin g an d Preven tio n defin es a medicatio n erro r as: “ … an y p reven table even t that may cause o r lead to in ap p ro p riate medicatio n use o r p atien t harm while the medicatio n is in the co n tro l o f the healthcare p ro fessio n al, p atien t, o r co n sumer. Such even ts may be related to p ro fessio n al p ractice, health care p ro ducts, p ro cedures, an d systems, in cludin g p rescribin g; o rder co mmun icatio n ; p ro duct labelin g, p ackagin g, an d n o men clature; co mp o un din g; disp en sin g; distributio n ; admin istratio n ; educatio n ; mo n ito rin g; an d use.” Ho wever, there is n o widely accep ted un ifo rm defin itio n . Un fo rtun ately, un to ward medical erro rs an d un derrep o rted medicatio n erro rs result in sign ifican t mo rbidity an d mo rtality.[4 ][3 ][5 ][6 ] Adverse Drug Reaction The Wo rld Health Organ iz atio n defin es an adverse drug reactio n as “ an y resp o n se that is n o xio us, un in ten ded, o r un desired, which o ccurs at do ses n o rmally used in human s fo r p ro p hylaxis, diagn o sis, therap y o f disease, o r mo dificatio n o f p hysio lo gical fun ctio n .” Adverse drug reactio n s are exp ected n egative o utco mes that are in heren t to the p harmaco lo gic actio n o f the drug an d n o t always p reven table, while medicatio n erro rs are p reven table.[7 ][8 ][9 ] Adverse Drug Event An adverse drug even t is an in jury fro m a medicatio n o r a missed o r in ap p ro p riately do sed medicatio n . An adverse drug even t causes mo rbidity o r mo rtality to a p atien t. The differen ce between an adverse drug reactio n an d an adverse drug even t is that in an adverse drug even t, the p atien t must be exp o sed to a medicatio n with a n egative co n seq uen ce, which may o r may n o t be exp ected. Fo r adverse drug even ts, the p atien t suffers a n egative co n seq uen ce fro m receivin g a drug in the usual man n er it was in ten ded, did n o t receive a medicatio n that was req uired, o r received the medicatio n in a man n er that was in ap p ro p riate such as to o high o r lo w a do se.[1 0 ][1 1 ][1 2 ] Medication Misadventure A medicatio n misadven ture is an iatro gen ic in ciden t that is in heren t to medicatio n therap y. Medicatio n misadven ture in cludes medicatio n erro rs, adverse drug reactio n s, an d adverse drug even ts. It is created thro ugh o missio n o r co mmissio n o f medicatio n admin istratio n . Medicatio n misadven tures always are un desirable an d un exp ected; they may o r may n o t be in dep en den t o f p reexistin g p atho lo gy; an d might be due to human o r system erro r, idio syn cratic, o r immun o lo gic resp o n se.[1 3 ][1 4 ][1 5 ] Sentinel Event The Jo in t Co mmissio n defin es a sen tin el even t as “ an un exp ected o ccurren ce in vo lvin g death o r serio us p hysical o r p sycho lo gical in jury, o r the risk thereo f. Serio us in jury sp ecifically in cludes lo ss o f limb o r fun ctio n . The p hrase ‘ o r the risk thereo f’ in cludes an y p ro cess variatio n fo r which a recurren ce wo uld carry a sign ifican t chan ce o f a serio us adverse o utco me.” Sen tin al even ts may in clude medicatio n erro rs, adverse drug even ts, an d medicatio n misadven tures. Sen tin el even ts cause sign ifican t mo rbidity o r mo rtality an d are p o ssibly p reven table.[1 6 ][1 7 ][1 8 ] Fun c tio n Medicatio n erro rs can o ccur at man y step s in p atien t care, fro m o rderin g the medicatio n to the time when the p atien t is admin istered the drug. In gen eral, medicatio n erro rs usually o ccur at o n e o f these p o in ts: Orderin g/p rescribin g Do cumen tin g Tran scribin g Disp en sin g Admin isterin g Mo n ito rin g Medicatio n erro rs are mo st co mmo n at the o rderin g o r p rescribin g stage. Typ ical erro rs in clude the healthcare p ro vider writin g the wro n g medicatio n , the wro n g ro ute o r do se, o r the wro n g freq uen cy. These o rderin g erro rs acco un t fo r almo st 5 0 % o f medicatio n erro rs. Data sho w that n urses an d p harmacists iden tify an ywhere fro m 3 0 % to 7 0 % o f medicatio n -o rderin g erro rs. It is o bvio us that medicatio n erro rs are a p ervasive p ro blem, but the p ro blem is p reven table in mo st cases.[1 9 ] Issues o f C o n c ern Medicatio n erro rs are gro up ed by differen t taxo n o mies by the Jo in t Co mmissio n , Wo rld Health Organ iz atio n , an d The Natio n al Co o rdin atin g Co un cil fo r Medicatio n Erro r Rep o rtin g an d Preven tio n .[2 0 ][2 1 ][2 2 ] So me taxo n o mies co n sider the so urce o f the erro r: Deterio rated drug erro r fro m co mp ro mised sto rage Drug utiliz atio n p ro cess erro rs fro m the admin istratio n , disp en sin g, o r mo n ito rin g Prescribin g erro rs The mo st co mmo n system failures in clude: In accurate o rder tran scrip tio n Drug kn o wledge dissemin atio n Failin g to o btain allergy histo ry In co mp lete o rder checkin g Mistakes the trackin g o f the medicatio n o rders Po o r p ro fessio n al co mmun icatio n Un availability o r in accurate p atien t in fo rmatio n The Agen cy fo r Healthcare Research an d Quality, to better stan dardiz e medicatio n rep o rtin g, develo p ed the Co mmo n Fo rmats, which are defin ed data elemen ts co llected an d rep o rted in the even t o f a medicatio n erro r thro ugh the Patien t Safety Organ iz atio n Privacy Pro tectio n Cen ter. The sco p e o f the Co mmo n Fo rmats en co mp asses all erro rs, in cludin g even ts that tho se that have the p o ten tial to affect the p atien t, n ear-misses, an d tho se that have a p atien t effect.[2 3 ][2 4 ] [2 5 ] Co mmo n medicatio n erro r typ es are: In co rrect p atien t In co rrect medicatio n o r erro r o f co mmissio n Types of Medication Errors Prescribin g Omissio n Wro n g time Un autho riz ed drug Imp ro p er do se Wro n g do se p rescrip tio n /wro n g do se p rep aratio n Admin istratio n erro rs in clude the in co rrect ro ute o f admin istratio n , givin g the drug to the wro n g p atien t, extra do se, o r wro n g rate Mo n ito rin g erro rs such as failin g to take in to acco un t p atien t liver an d ren al fun ctio n , failin g to do cumen t allergy o r p o ten tial fo r drug in teractio n Co mp lian ce erro rs such as n o t fo llo win g p ro to co l o r rules established fo r disp en sin g an d p rescribin g medicatio n s Causes of Medication Errors Expired Product Usually o ccurs due to imp ro p er sto rage o f p rep aratio n s resultin g in deterio ratio n o r use o f exp ired p ro ducts. Incorrect Duration Duratio n erro rs o ccur when medicatio n is received fo r a lo n ger o r sho rter p erio d o f time than p rescribed. Incorrect Preparation This erro r usually o ccurs with co mp o un din g o r so me o ther typ e o f p rep aratio n befo re the fin al admin istratio n . An examp le is cho o sin g the in co rrect diluen t to reco n stitute. Incorrect Strength In co rrect stren gth may p o ten tially o ccur at man y p o in ts in the medicatio n p ro cess. It usually o ccurs due to human erro r when similar bo ttles o r syrin ges with the in co rrect stren gth is selected. Incorrect Rate Mo st o ften o ccurs with medicatio n s that are given as IV p ush o r in fusio n s. This is p articularly dan gero us with man y drugs an d may result in sign ifican t adverse drug reactio n s. Examp les in clude tachycardia due to rap id IV ep in ep hrin e o r red man syn dro me due to the rap id admin istratio n o f van co mycin . Incorrect Timing In bo th ho me an d in stitutio n al settin gs, it is challen gin g to be co mp letely accurate with scheduled do ses. The co n cern is that so me medicatio n 's abso rp tio n is sign ifican tly altered if taken with o r witho ut fo o d. As such, it is imp o rtan t to adhere to scheduled times as co mmo n ly; this may lead to un der o r o verdo sin g. Incorrect Dose This erro r in cludes o verdo se, un derdo se, an d an extra do se. An in co rrect do se o ccurs when an in ap p ro p riate o r differen t medicatio n do se is given o ther than what was o rdered, erro rs o f o missio n when a scheduled do se o f medicatio n is n o t given , an d when a drug is given via an in co rrect ro ute. Erro rs due to in co rrect ro utes usually o ccur due to un clear labelin g o r tubin g that is adap tive to multip le co n n ecto rs/lin es o f access. In co rrect ro utes o ften result in result in sign ifican t mo rbidity an d mo rtality.[2 6 ][2 7 ][2 8 ] Incorrect Dosage Form This o ccurs when a p atien t receives a do sage fo rm differen t than p rescribed, such as immediate-release in stead o f exten ded-release. Incorrect Patient Action This o ccurs when a p atien t takes a medicatio n in ap p ro p riately. Patien t educatio n is the o n ly way to p reven t this typ e o f erro r. Known Allergen Disp en sin g a drug that the p atien t has an allergy o ften due to failure to co mmun icate with the p atien t, in ap p ro p riate chart review, in accurate chartin g, o r lack o f techn o lo gical in terface. Known Contraindication This o ccurs when medicatio n s are n o t vigilan tly reviewed fo r drug-drug, drug-disease, o r drug-n utrien t in teractio n s. Pharmacist Erro rs by p harmacists are usually judgmen tal o r mechan ical. Judgmen tal erro rs in clude failure to detect drug in teractio n s, in adeq uate drug utiliz atio n review, in ap p ro p riate screen in g, failure to co un sel the p atien t ap p ro p riately, an d in ap p ro p riate mo n ito rin g. A mechan ical erro r is a mistake in disp en sin g o r p rep arin g a p rescrip tio n , such as admin isterin g an in co rrect drug o r do se, givin g imp ro p er directio n s, o r disp en sin g the in co rrect do se, q uan tity, o r stren gth. The mo st co mmo n causes in vo lve wo rklo ad, similar drug n ames, in terrup tio n s, lack o f sup p o rt staff, in sufficien t time to co un sel p atien ts, an d illegible han dwritin g. Distractions On e o f the majo r causes o f medicatio n erro rs is distractio n . Nearly 7 5 % o f medicatio n erro rs have been attributed to this cause. Physician s have man y duties in a ho sp ital (e.g., examin in g p atien ts, o rderin g labo rato ry an d imagin g studies, sp eakin g to co n sultan ts, ro un din g o n their p atien ts, sp eakin g to p atien t family members, co n versin g with in suran ce carriers befo re o rderin g studies), an d in the midst o f all this, they are o ften asked to write drug o rders an d p rescrip tio n s. In the rush to be do n e with writin g drug o rders, so metimes a lap se o f judgmen t develo p s, an d a medicatio n erro r o ccurs. It can hap p en to the best p hysician . So metimes the p hysician may be o n the p ho n e, an d a clin ician may be stan din g with the o rder chart n ext to him o r her askin g fo r a drug o rder. The p hysician may q uickly scribble in a drug o rder, n o t p ayin g atten tio n to the do se o r freq uen cy. It is the un scheduled even ts in the life o f a healthcare p ro vider such as the co n stan t p ages, atten dan ce at meetin gs, an d an swerin g telep ho n e calls that disrup t p atien t care. Man y p hysician s do n o t ackn o wledge that these distractio n s are a p ro blem, but in reality, these distractio n s are o ften the cause o f medicatio n erro rs.[2 9 ] To min imiz e distractio n s, ho sp itals have in tro duced measures to reduce medicatio n erro rs. Mo st ho sp itals are wo rkin g o n ways to decrease distractio n s to en sure that medicatio n o rders do n o t o ccur. Fo r examp le, p hysician s are urged to o rder drugs at a set time after ro un din g o n their p atien ts; this is when they also write their daily p ro gress n o tes. Other clin ician s are req uested n o t to disturb the p hysician at this time o f the day. Also , clin ician s are asked o n ly to disrup t the p hysician fo r an emergen cy. Physician s are bein g urged to develo p a structure fo r their p atien t care that is o rgan iz ed so that distractio n s are limited. While an swerin g a p age is o ften n ecessary, man y ho sp itals reco mmen d that p hysician s n o t an swer p atien t calls un til p atien t duties are co mp leted. Additio n ally, healthcare in stitutio n s are n o w p en aliz in g p hysician s who co n tin ue to have to o man y medicatio n erro rs because o f distractio n s; the result is a restrictio n in p rescribin g p rivileges. Of co urse, n o t all distractio n s can be elimin ated because the p ractice o f medicin e is itself un p redictable an d chao tic at the best o f times. Distortions A p revalen t cause o f medicatio n erro rs is disto rtio n s. The majo rity o f disto rtio n s may o rigin ate fro m p o o r writin g, misun dersto o d symbo ls, the use o f abbreviatio n s, o r imp ro p er tran slatio n . A sign ifican t n umber o f healthcare p ro viders in the Un ited States are fro m fo reign co un tries an d o ften write o rders fo r medicatio n s that are n o t even available do mestically. When a p ractitio n er q uestio n s the drug, the p hysician o ften asks the n urse o r p harmacist to substitute the medicatio n p rescribed fo r a similar drug. This typ e o f disto rtio n can lead to majo r erro rs because n either the n o n -p rescribin g p ractitio n er n o r the p harmacist can substitute a drug. All ho sp ital p harmacies have a list o f medicatio n s available in the fo rmulary, an d do cto rs sho uld kn o w what is available an d limit the o rderin g fro m this list. Illegible Writing Illegible writin g has p lagued bo th n urses an d p harmacists fo r decades. Physician s are o ften in a hurry an d freq uen tly scribble do wn o rders that are n o t legible; this o ften results in majo r medicatio n mistakes. Takin g sho rtcuts in writin g drug o rders is a p rescrip tio n fo r a lawsuit. Often the p ractitio n er o r the p harmacist is n o t able to read the o rder an d makes their best guess. If the drug req uired is a dire emergen cy, this also adds mo re risk to the p atien t. To elimin ate such erro rs, mo st ho sp itals have rules that p ractitio n ers an d p harmacists have to fo llo w; if the drug o rder is illegible, the p hysician must be called an d asked to rewrite the o rder clearly. The p ractitio n er o r the p harmacist sho uld n ever guess what the drug/do se is. The bad writin g by p hysician s has beco me such a majo r p ro blem that the In stitute o f Safe Medicatio n Practices has reco mmen ded the co mp lete elimin atio n o f han dwritten o rders an d p rescrip tio n s. This p ro blem has been reso lved usin g electro n ic reco rds where everythin g is typ ed, an d p o o r writin g is n o lo n ger an issue; ho wever, erro rs still can o ccur fro m writin g the wro n g drug, do se, o r freq uen cy.[3 0 ][3 1 ] Approach every prescription with caution. There have been man y n ew drug releases in the last decade, an d gen erics with similar n ames have flo o ded the market. In additio n to havin g similar n ames, man y o f these medicatio n s have multip le uses an d altern ative n ames. If the diagn o sis is n o t stated o n the p rescrip tio n , there is a risk that the drug may be p rescribed fo r to o lo n g o r an in adeq uate amo un t o f time. With do z en s o f n ew gen erics with similar n ames, the risk o f erro r is very high. To co un ter the co n seq uen ces o f un in ten ded substitutio n s fo r medicatio n s, the US Pharmaco p eia has listed the n ames o f lo o k-alike medicatio n s, an d the ISMP has develo p ed a list o f abbreviatio n s that are ro utin ely misin terp reted.[3 0 ] Write down the precise dosage. Disto rtio n o f a do se can easily o ccur when n o n sp ecific abbreviatio n s o r decimal p o in ts are used witho ut tho ught. On e abbreviatio n that is o ften the cause o f medicatio n erro rs is the \"Ug\" symbo l fo r micro grams. It is o ften mistaken fo r un its an d sho uld be avo ided at all co sts. It is best to sp ell o ut the q uan tity. Use metric measures: The use o f ap o thecary measures are n o w p art o f the histo rical archives; weight measures like grain s, drams, an d min ims have little mean in g to the mo dern -day healthcare wo rkers an d sho uld n o lo n ger be used. In stead, use the un iversal metric measures that are p referred by p harmacists an d p ractitio n ers. When usin g metric measures, be careful when an d where yo u use the decimal p o in t. Fo r examp le, when writin g dexamethaso n e 2 .0 mg, if the decimal p o in t is n o t visualiz ed, the n urse o r the p harmacist may thin k it is 2 0 mg. On the o ther han d, a z ero sho uld always p recede a decimal p o in t. Fo r examp le, when writin g digo xin , it sho uld be written as 0 .2 5 mg an d n o t just .2 5 mg. Again , if the decimal p o in t is n o t seen , it can easily lead to a ten fo ld in crease in do se. Consider patient age: The two p o p ulatio n s that are very sen sitive to medicatio n s are the elderly an d children . Always check the p atien t’ s age an d bo dy weight to en sure that the do se admin istered is co rrect. Also , if yo u write a p rescrip tio n , write the p atien t's age an d weight o n it so that the p harmacist un derstan ds ho w yo u derived the do se. In children , mo st drugs are p rescribed based o n bo dy weight. Liver and kidney function: An o ther widesp read reaso n fo r medicatio n erro rs is n o t co n siderin g ren al o r liver failure. Patien ts with ren al an d liver dysfun ctio n n eed lo wer do ses. Otherwise, to xicity can result because o f the failure to excrete o r break do wn the medicatio n . Provide directions: Healthcare wo rkers who write drug o rders an d p rescrip tio n s sho uld n ever assume that the o ther p arty kn o ws what yo u mean . Pro vide clear in structio n s o n do ses, the n umber o f p ills, an d ho w an d when the medicatio n is to be taken . Writin g o rders like \"take as directed\" is a recip e fo r disaster. Similarly, \"PRN\" witho ut an in dicatio n sho uld n ever be used. It is an erro r in the makin g. Write do wn when the drug is to be taken an d fo r what p urp o se (e.g., take 2 mg o f mo rp hin e by mo uth fo r p ain . Take the mo rp hin e every 3 to 4 ho urs as n eeded fo r p ain ). Reducin g medicatio n erro rs req uires o p en co mmun icatio n between the p atien t an d the p harmacist.[3 2 ] Use of Abbreviations: On e widesp read cause o f medicatio n erro rs is the use o f abbreviatio n s. Often the freq uen cy o f admin istratio n is abbreviated usin g suffixes like QD, OS, TID, QID, PR, etc. QD (mean in g o n ce a day) can easily be mistaken fo r QID (fo ur times a day). Additio n ally, these abbreviatio n s can have several o ther mean in gs an d can be misin terp reted. It is reco mmen ded that abbreviatio n s n o t be used at all when writin g medicatio n o rders.[3 3 ] Duration of treatment: In the p ast, so me p hysician s wo uld simp ly write do wn the to tal n umber o f p ills that a p atien t is sup p o sed to get witho ut sp ecifyin g the duratio n o f treatmen t. It is vital to sp ecify the duratio n o f treatmen t an d that the duratio n o f treatmen t matches the n umber o f p ills p rescribed. When writin g abo ut the q uan tity o f the drug, it is imp o rtan t to write do wn the actual n umber o f p ills (e.g., 9 0 ) rather than statin g disp en se fo r 2 mo n ths. An o ther reaso n fo r sp ecifyin g the n umber o f do ses is that it req uires the p atien t to co mp ly with fo llo w-up an d p reven ts them fro m just co llectin g o lder medicatio n s. If the p atien t has a chro n ic diso rder, the p ractitio n er sho uld be treatin g each flare-up as a sin gle even t with a fin ite n umber o f p ills. If the p atien t has a flare-up o r exacerbatio n , tell him o r her to co me to the clin ic fo r an exam an d, at that time, determin e if mo re p ills are n eeded. Just emp irically p rescribin g p ills fo r a theo retical recurren ce o n ly leads to co n fusio n an d a high risk o f adverse reactio n s. Remain alert for high-risk medications. Fo r examp le, if a p atien t has a deep vein thro mbo sis o r a p ro sthetic heart valve an d req uires warfarin , o n ly p rescribe fo r 4 weeks at a time an d reassess the p atien t o n each visit. Do n o t give warfarin fo r man y mo n ths at a time. The p atien t n eeds to be mo n ito red fo r the INR, an d the do se may have to be adjusted.[3 4 ] Always specify the indication for the drug. Writin g the in dicatio n fo r the drug is highly reco mmen ded because man y drugs have multip le uses. Un fo rtun ately, the majo rity o f p rescrip tio n s n ever have the diagn o sis written , an d o mittin g this in fo rmatio n in creases the p o ten tial fo r co mp licatio n s. Writin g the diagn o sis in fo rms the p harmacist o f the diagn o sis an d remin ds the p atien t o f the medicatio n 's p urp o se. This small step can facilitate co un selin g by the p harmacist, rein fo rce the p atien t's treatmen t p lan , an d p ro vide amp le o p p o rtun ities fo r p atien t educatio n . It also help s imp ro ve co mmun icatio n between the healthcare p ro vider an d the p harmacist. Fo r examp le, co rtico stero ids an d an tico n vulsan ts have man y uses, an d the p harmacist n eeds to kn o w what co n ditio n is bein g treated.[3 5 ] An an tico n vulsan t may be used to treat a migrain e, n euro p athic p ain , o r behavio r, besides seiz ures. Choose the appropriate drug for the patient population: When dealin g with elderly p atien ts, healthcare p ro viders sho uld avo id o rderin g drugs listed o n the Beers criteria- this list o f drugs is kn o wn to have the p o ten tial to cause adverse reactio n s in elderly in dividuals.[3 6 ] Add supplemental instructions. Always add extra p recautio n s when n ecessary. Fo r examp le, when p rescribin g tetracyclin es, the p atien t sho uld be warn ed abo ut sun exp o sure, o r when takin g ibup ro fen , the p atien t sho uld be to ld to take the medicatio n with fo o d. When p rescribin g metro n idaz o le, warn the p atien t abo ut alco ho l use. Do n o t assume that the p harmacist will add these extra warn in gs when disp en sin g the drugs. Fo r p atien ts who can n o t read o r un derstan d the in structio n s fo r p rescribed medicatio n s, educate the family, an d p ro vide verbal co un selin g when req uired. Adopt a reporting system. The o n ly way to reduce medicatio n erro rs is to develo p a rep o rtin g system an d then make chan ges to p reven t similar erro rs fro m reo ccurrin g. Even a n ear miss sho uld be rep o rted. The staff sho uld be en co uraged to rep o rt witho ut an y rep ercussio n s. It is a great learn in g exp erien ce an d en han ces safety. Discuss the patient's preferences. Co n siderin g the man y drugs available to treat the same diso rder, in vo lve the p atien t in decisio n makin g. The p atien t sho uld be to ld abo ut the p o ten tial adverse effects an d cautio n s. Write your contact number. Man y healthcare p ro viders write p rescrip tio n s o r o rders in the chart an d o ften do n o t leave a co n tact n umber. If there is a q uery abo ut the drug, then the p harmacist an d n urse are left o n their o wn , an d co n seq uen tly, the p atien t misses o ut o n the medicatio n . Who Is to blame: The Healthcare Professional or the System? In the p ast, when medicatio n erro rs o ccurred, the in dividual who caused it was usually blamed fo r the mishap . Medicatio n erro rs related to emp lo yees may be due to the fo llo win g: Negligen ce Fo rgetful Hurryin g Po o r mo tivatio n Ven gean ce Carelessn ess In such situatio n s, discip lin ary actio n s may in clude: Blame an d shame Lo ss o f p rivileges A threat o f a medical malp ractice lawsuit Relief fro m certain duties Tran sfer to an o ther dep artmen t This culture o f blame has shifted, an d medicatio n erro rs are believed to be a systemic p ro blem. Erro rs in the system may be viewed as the result an d n o t the cause. Thus, rather than fo cusin g o n chan gin g the behavio r o f every healthcare wo rker, ho sp itals are n o w tryin g to un derstan d ho w the system failed. This ap p ro ach is design ed to in tro duce barriers an d safeguards at every level so that a mistake can be caught befo re the drug is given to the p atien t. In man y cases, mistakes are made by so me o f the well-train ed healthcare p ro fessio n als, an d rather than blame them; o n e sho uld try an d un derstan d why the erro r o ccurred. In man y cases, erro rs o ccur in recurren t p attern s, irresp ective o f the healthcare wo rker in vo lved.[3 7 ] Medication Error Risk Factors High vo lume Po o r han dwritin g In exp erien ced staff Challen gin g p atien t p o p ulatio n s Lack o f fo llo w-up Lack o f ap p ro p riate mo n ito rin g Lack o f p o licy en fo rcemen t Medically co mp lex p atien ts Medicatio n s req uirin g calculatio n s En viro n men tal facto rs Po o r co mmun icatio n Shift wo rk Wo rkp lace culture Verbal o rders In terp erso n al facto rs such as extern al stress Pharmacy Error Prevention Man y adverse drug even ts are p reven table, as they are o ften due to human erro r. Co mmo n causes o f erro r related to the p harmacists in clude failure to : Deliver the co rrect do sage Iden tify co n train dicatio n to drug therap y. Iden tify a drug allergy. Mo n ito r drugs with n arro w therap eutic in dexes Reco gn iz e drug in teractio n Reco gn iz e kn o wledge deficits Often these erro rs can be avo ided by sp en din g time talkin g sp eakin g to the p atien t an d do uble-checkin g their un derstan din g o f the do se, drug allergies, an d reviewin g an y o ther medicatio n s they may be takin g. Barriers to successful co mmun icatio n in clude the in ability to reach p rescribers, un clear verbal an d written o rders an d time co n strain ts that make it challen gin g to check drug in teractio n s.[3 8 ] A p harmacist's resp o n sibilities o ften in clude sup ervisin g p atien ts' medicatio n treatmen t an d n o tifyin g the healthcare team when a discrep an cy is fo un d. Mo st medicatio n discrep an cies are fo un d at discharge, highlightin g the n eed fo r a p harmacist to assist in the discharge p ro cess.[3 9 ] Systems-Based Drug Safety In the p ast, p ractitio n ers have bo rn e the blame fo r medicatio n erro rs. This has resulted in un derrep o rtin g an d an en viro n men t that fails to p ro mo te safety imp ro vemen t. The reality is that man y erro rs are due to p o o r system design an d o ver exp ectatio n o f human p erfo rman ce. Imp ro vin g p atien t safety starts with develo p in g a cultural fo cus o n safety imp ro vemen t. The team must wo rk to gether, an d when an erro r is iden tified, the go al is to p reven t it fro m hap p en in g again rather than blame the in dividual.[4 0 ] C lin ic a l Sign ific a n c e Medicatio n erro rs are a co mmo n issue in healthcare an d co st billio n s o f do llars n atio n wide while in flictin g sign ifican t mo rbidity an d mo rtality. While n atio n al atten tio n has been p aid to erro rs in medicatio n disp en sin g issues, it remain s a widesp read p ro blem. The best metho d to en han ce p atien t safety is to develo p a multi-faceted strategy fo r educatio n an d p reven tio n . Emp hasis sho uld be p ut o n healthcare p ro viders wo rkin g as a team an d co mmun icatin g as well as en co uragin g p atien ts to be mo re in fo rmed abo ut their medicatio n s. With a culture o f safety, disp en sin g medicatio n erro rs can be reduced. Other Issues Other Strategies to Reduce Medication Errors Over the years, ho sp itals have develo p ed strategies to p reven t medicatio n erro rs. So me o f these strategies in clude the fo llo win g: Do uble-check the do sin g an d freq uen cy o f all high-alert medicatio n s. The In stitute o f Safe Medicatio n Practices p ro vides a list o f high-alert medicatio n s. If un sure abo ut the drug o r the do se, sp eak to the p harmacist. If the writin g is illegible, do n o t give the medicatio n believin g that yo u thin k yo u kn o w what it is. Call the healthcare p ro vider to co n firm the drug o r do se. Recheck the calculatio n to en sure that the p atien t will get the right therap eutic do se. Ask an o ther clin ician to recheck yo ur calculatio n s.[4 1 ] Preventing Medication Errors Always write o n e p rescrip tio n fo r each medicatio n . Besides sign in g the p rescrip tio n , always circle yo ur n ame o n the p rep rin ted p rescrip tio n p ad. Do n o t hesitate to check the do se an d freq uen cy if yo u are n o t sure. Always co n sider the fact that each medicatio n has the p o ten tial fo r adverse reactio n s. Do n o t use drug abbreviatio n s when writin g o rders. Always add the p atien t’ s age an d weight to each p rescrip tio n . Check fo r liver an d ren al fun ctio n befo re o rderin g an y medicatio n . Sp ell o ut the freq uen cy an d ro ute o f do sage; do n o t use abbreviatio n s. Always sp ecify the duratio n o f therap y; do n o t say give o ut \"XXX\" n umber o f p ills. Always be aware o f high-risk medicatio n s. When writin g a p rescrip tio n , state the co n ditio n bein g treated. En ha n c in g Hea lthc a re Tea m Outc o mes 1 . 2 . 3 . 4 . 5 . Writin g p rescrip tio n s an d medicatio n o rders is an everyday jo b duty fo r man y healthcare wo rkers, in cludin g n urse p ractitio n ers. Ho wever, the in creased deman ds to see mo re p atien ts who req uire man y medicatio n s o ften beco me mo n o to n o us, an d o n e can beco me careless. The majo rity o f healthcare wo rkers n ever an ticip ate an adverse drug even t, an d co n seq uen tly, rarely check back with the p harmacists fo r drug in teractio n s. With a high n umber o f medicatio n -related erro rs, healthcare wo rkers are un der great scrutin y to chan ge their wo rk habits an d ado p t a culture o f safety when writin g drug o rders an d p rescrip tio n s. Tho ugh there is n o sin gle way to elimin ate all drug erro rs, healthcare wo rkers can reduce erro rs by beco min g mo re cautio us an d in teractin g clo sely with o ther p ractitio n ers, p harmacists, an d p atien ts. Op en an d direct co mmun icatio n is o n e way to bridge the safety gap . An in terp ro fessio n al team wo rkin g to gether is imp o rtan t to achieve accurate medicatio n utiliz atio n an d decreased erro rs. Clin ician s o rder medicatio n s, p harmacists, fill them, an d n urses an d p atien ts admin ister them. Imp ro vemen ts in this chain o f co mmun icatio n will ultimately p ro vide better p atien t care with decreased mo rbidity an d mo rtality. Better p atien t educatio n o n their medicatio n o ffers a check an d balan ce o n the health p ro fessio n als an d in creases safety co mp lian ce. Communication When p harmacists co mmun icate with p rescribers an d n urses, the p harmacist sho uld: Outlin e the p ro blem an d then p ro vide details Offer p o ssible so lutio n s, in cludin g substitute medicatio n s. Rep eat back the o rder o r o rder chan ges Co n firm un derstan din g Do cumen t co n versatio n an d decisio n An en viro n men t o f teamwo rk is mo st co n ducive to o p timal medicatio n delivery. The team sho uld n o t fear discussio n an d reso lutio n o f co n flicts. Lack o f in terp ro fessio n al co mmun icatio n limits the disco very o f medicatio n erro rs an d un co verin g their ro o t cause. Op en discussio n amo n gst the team sho uld be en co uraged. [Level 5 ] Review Questio n s Access free multip le cho ice q uestio n s o n this to p ic. Co mmen t o n this article. Referen c es Wittich CM, Burkle CM, Lan ier WL. Medicatio n erro rs: an o verview fo r clin ician s. Mayo Clin Pro c. 2 0 1 4 Aug; 8 9 (8 ): 1 1 1 6 -2 5 . [PubMed: 2 4 9 8 1 2 1 7 ] Whittaker CF, Miklich MA, Patel RS, Fin k JC. Medicatio n Safety Prin cip les an d Practice in CKD. Clin J Am So c Nep hro l. 2 0 1 8 No v 0 7 ; 1 3 (1 1 ): 1 7 3 8 -1 7 4 6 . [PMC free article: PMC6 2 3 7 0 5 7 ] [PubMed: 2 9 9 1 5 1 3 1 ] Ibrahim OM, Ibrahim RM, Meslaman i AZA, Maz ro uei NA. Disp en sin g erro rs in co mmun ity p harmacies in the Un ited Arab Emirates: in vestigatin g in ciden ce, typ es, severity, an d causes. Pharm Pract (Gran ada). 2 0 2 0 Oct- Dec; 1 8 (4 ): 2 1 1 1 . [PMC free article: PMC7 6 0 3 6 5 7 ] [PubMed: 3 3 1 4 9 7 9 3 ] Zirp e KG, Seta B, Gho lap S, Auran gabadi K, Gurav SK, Deshmukh AM, Wan khede P, Suryawan shi P, Vasan th S, Kurian M, Philip E, Jagtap N, Pan dit E. In ciden ce o f Medicatio n Erro r in Critical Care Un it o f a Tertiary Care Ho sp ital: Where Do We Stan d? In dian J Crit Care Med. 2 0 2 0 Sep ; 2 4 (9 ): 7 9 9 -8 0 3 . [PMC free article: PMC7 5 8 4 8 4 1 ] [PubMed: 3 3 1 3 2 5 6 3 ] Sim MA, Ti LK, Mujumdar S, Chew STH, Pen an ueva DJB, Kumar BM, An g SBL. Sustain in g the Gain s: A 7 - 6 . 7 . 8 . 9 . 1 0 . 1 1 . 1 2 . 1 3 . 1 4 . 1 5 . 1 6 . 1 7 . 1 8 . 1 9 . 2 0 . 2 1 . 2 2 . Year Fo llo w-Thro ugh o f a Ho sp ital-Wide Patien t Safety Imp ro vemen t Pro ject o n Ho sp ital-Wide Adverse Even t Outco mes an d Patien t Safety Culture. J Patien t Saf. 2 0 2 2 Jan 0 1 ; 1 8 (1 ): e1 8 9 -e1 9 5 . [PubMed: 3 2 3 9 8 5 3 7 ] Aseeri M, Ban asser G, Baduhduh O, Baksh S, Ghalibi N. Evaluatio n o f Medicatio n Erro r In ciden t Rep o rts at a Tertiary Care Ho sp ital. Pharmacy (Basel). 2 0 2 0 Ap r 1 9 ; 8 (2 ) [PMC free article: PMC7 3 5 6 7 4 7 ] [PubMed: 3 2 3 2 5 8 5 2 ] Neal JM, Neal EJ, Wein berg GL. American So ciety o f Regio n al An esthesia an d Pain Medicin e Lo cal An esthetic Systemic To xicity checklist: 2 0 2 0 versio n . Reg An esth Pain Med. 2 0 2 1 Jan ; 4 6 (1 ): 8 1 -8 2 . [PubMed: 3 3 1 4 8 6 3 0 ] Kefale B, Degu A, Tegegn e GT. Medicatio n -related p ro blems an d adverse drug reactio n s in Ethio p ia: A systematic review. Pharmaco l Res Persp ect. 2 0 2 0 Oct; 8 (5 ): e0 0 6 4 1 . [PMC free article: PMC7 4 5 9 1 6 4 ] [PubMed: 3 2 8 6 9 5 3 1 ] Go n z aga de An drade San to s TN, Men do n ç a da Cruz Macieira G, Cardo so So dré Alves BM, On o z ato T, Cun ha Cardo so G, Ferreira Nascimen to MT, Saq uete Martin s-Filho PR, Pereira de Lyra D, Oliveira Filho AD. Prevalen ce o f clin ically man ifested drug in teractio n s in ho sp italiz ed p atien ts: A systematic review an d meta- an alysis. PLo S On e. 2 0 2 0 ; 1 5 (7 ): e0 2 3 5 3 5 3 . [PMC free article: PMC7 3 2 9 1 1 0 ] [PubMed: 3 2 6 0 9 7 8 3 ] Uhlen ho p p DJ, Aguilar O, Dai D, Gho sh A, Shaw M, Mitra C. Ho sp ital-Wide Medicatio n Reco n ciliatio n Pro gram: Erro r Iden tificatio n , Co st-Effectiven ess, an d Detectin g High-Risk In dividuals o n Admissio n . In tegr Pharm Res Pract. 2 0 2 0 ; 9 : 1 9 5 -2 0 3 . [PMC free article: PMC7 5 6 8 6 3 0 ] [PubMed: 3 3 1 1 7 6 6 6 ] Mo hamo ud M, Ho rgan C, Ewo ruke E, Dee E, Bo hn J, Shap ira O, Mun o z MA, Sto jan o vic D, San sin g-Fo ster V, Ajao A, La Gren ade L. Co mp lemen tary Use o f U.S. FDA's Adverse Even t Rep o rtin g System an d Sen tin el System to Characteriz e Direct Oral An tico agulan ts-Asso ciated Cutan eo us Small Vessel Vasculitis. Pharmaco therap y. 2 0 2 0 No v; 4 0 (1 1 ): 1 0 9 9 -1 1 0 7 . [PMC free article: PMC8 9 3 8 9 5 7 ] [PubMed: 3 3 0 9 0 5 3 0 ] Ahsan uddin S, Ro y S, Nasser W, Po vo lo tskiy R, Paskho ver B. Adverse Even ts Asso ciated With Bo to x as Rep o rted in a Fo o d an d Drug Admin istratio n Database. Aesthetic Plast Surg. 2 0 2 1 Jun ; 4 5 (3 ): 1 2 0 1 -1 2 0 9 . [PubMed: 3 3 1 2 8 0 7 6 ] Zaidi AS, Peterso n GM, Berez n icki LRE, Curtain CM, Salahudeen M. Outco mes o f Medicatio n Misadven ture Amo n g Peo p le With Co gn itive Imp airmen t o r Demen tia: A Systematic Review an d Meta-an alysis. An n Pharmaco ther. 2 0 2 1 Ap r; 5 5 (4 ): 5 3 0 -5 4 2 . [PubMed: 3 2 7 7 2 8 5 4 ] Talebrez a S, McPherso n ML. Reco gn iz in g an d Man agin g Po lyp harmacy in Advan ced Illn ess. Med Clin No rth Am. 2 0 2 0 May; 1 0 4 (3 ): 4 0 5 -4 1 3 . [PubMed: 3 2 3 1 2 4 0 6 ] Ben n ett G, Tain g MW, Hattin gh HL, La Caz e A. Pharmacists' p erceived resp o n sibility fo r p atien t care when there is a risk o f misadven ture: a q ualitative study. In t J Pharm Pract. 2 0 2 0 Dec; 2 8 (6 ): 5 9 9 -6 0 7 . [PubMed: 3 1 5 3 2 0 3 1 ] McGo wan J, Wo jahn A, Nico lin i JR. StatPearls [In tern et]. StatPearls Publishin g; Treasure Islan d (FL): Feb 1 0 , 2 0 2 2 . Risk Man agemen t Even t Evaluatio n an d Resp o n sibilities. [PubMed: 3 2 6 4 4 7 5 2 ] DeVin e JG, Chutkan N, Glo ystein D, Jackso n K. An Up date o n Wro n g-Site Sp in e Surgery. Glo bal Sp in e J. 2 0 2 0 Jan ; 1 0 (1 Sup p l): 4 1 S-4 4 S. [PMC free article: PMC6 9 4 7 6 7 5 ] [PubMed: 3 1 9 3 4 5 1 9 ] Niv Y, Cho rev N, Tal Y, Man o r O, Bro da A, Peer T, Mamado v M. [CULTURE OF SAFETY IN THE HOSPITAL]. Harefuah. 2 0 1 9 Aug; 1 5 8 (8 ): 5 2 0 -5 2 2 . [PubMed: 3 1 4 0 7 5 4 1 ] Wheeler AJ, Scahill S, Ho p cro ft D, Stap leto n H. Reducin g medicatio n erro rs at tran sitio n s o f care is everyo n e's busin ess. Aust Prescr. 2 0 1 8 Jun ; 4 1 (3 ): 7 3 -7 7 . [PMC free article: PMC6 0 0 3 0 1 4 ] [PubMed: 2 9 9 2 2 0 0 1 ] Chen R, Ho JC, Lin JS. Extractin g medicatio n in fo rmatio n fro m un structured p ublic health data: a demo n stratio n o n data fro m p o p ulatio n -based an d tertiary-based samp les. BMC Med Res Metho do l. 2 0 2 0 Oct 1 5 ; 2 0 (1 ): 2 5 8 . [PMC free article: PMC7 5 5 9 2 0 4 ] [PubMed: 3 3 0 5 9 5 8 8 ] Lo skuto va NY, Lutgen C, Smail C, Stato n EW, Nicho ls SD, Pin ckn ey RG. Stimulan t Prescribin g Erro r Assessmen t Rubric Develo p men t. J Patien t Saf. 2 0 2 2 Jan 0 1 ; 1 8 (1 ): e2 8 2 -e2 8 9 . [PubMed: 3 2 9 2 5 5 6 7 ] Röhsig V, Lo ren z in i E, Mutlaq MFP, Maestri RN, de So uz a AB, Alves BM, Wen dt G, Bo rges BG, Oliveira D. Near-miss an alysis in a large ho sp ital in so uthern Braz il: A 5 -year retro sp ective study. In t J Risk Saf Med. 2 0 2 0 ; 3 1 (4 ): 2 4 7 -2 5 8 . [PubMed: 3 2 5 6 8 1 1 8 ] 2 3 . 2 4 . 2 5 . 2 6 . 2 7 . 2 8 . 2 9 . 3 0 . 3 1 . 3 2 . 3 3 . 3 4 . 3 5 . 3 6 . 3 7 . 3 8 . 3 9 . 4 0 . Yo un t N, Zebrak KA, Famo laro T, So rra J, Birch R. Lin kin g Patien t Safety Culture to Quality Ratin gs in the Nursin g Ho me Settin g. J Ap p l Gero n to l. 2 0 2 2 Jan ; 4 1 (1 ): 7 3 -8 1 . [PubMed: 3 3 1 5 8 3 8 8 ] Radawski CA, Hammad TA, Co lilla S, Co p lan P, Ho rn buckle K, Freeman E, Smith MY, So bel RE, Bahri P, Arias AE, Ben n ett D. The utility o f real-wo rld eviden ce fo r ben efit-risk assessmen t, co mmun icatio n , an d evaluatio n o f p harmaceuticals: Case studies. Pharmaco ep idemio l Drug Saf. 2 0 2 0 Dec; 2 9 (1 2 ): 1 5 3 2 -1 5 3 9 . [PubMed: 3 3 1 4 6 9 0 1 ] Luetsch K, Ro wett D, Twigg MJ. A realist syn thesis o f p harmacist-co n ducted medicatio n reviews in p rimary care after leavin g ho sp ital: what wo rks fo r who m an d why? BMJ Qual Saf. 2 0 2 0 Oct 3 0 ; [PMC free article: PMC8 0 7 0 6 4 9 ] [PubMed: 3 3 1 2 7 8 3 5 ] Leahy IC, Lavo ie M, Zurako wski D, Baier AW, Brusto wicz RM. Medicatio n erro rs in a p ediatric an esthesia settin g: In ciden ce, etio lo gies, an d erro r reductio n strategies. J Clin An esth. 2 0 1 8 Sep ; 4 9 : 1 0 7 -1 1 1 . [PubMed: 2 9 9 1 3 3 9 3 ] Ho yle JD, Cro we RP, Ben tley MA, Beltran G, Fales W. Pediatric Preho sp ital Medicatio n Do sin g Erro rs: A Natio n al Survey o f Paramedics. Preho sp Emerg Care. 2 0 1 7 Mar-Ap r; 2 1 (2 ): 1 8 5 -1 9 1 . [PubMed: 2 8 2 5 7 2 4 9 ] Dhawan I, Tewari A, Sehgal S, Sin ha AC. Medicatio n erro rs in an esthesia: un accep table o r un avo idable? Braz J An esthesio l. 2 0 1 7 Mar - Ap r; 6 7 (2 ): 1 8 4 -1 9 2 . [PubMed: 2 8 2 3 6 8 6 7 ] Ro dz iewicz TL, Ho useman B, Hip skin d JE. StatPearls [In tern et]. StatPearls Publishin g; Treasure Islan d (FL): May 1 , 2 0 2 2 . Medical Erro r Reductio n an d Preven tio n . [PubMed: 2 9 7 6 3 1 3 1 ] Co hen MR, Smetz er JL. ISMP Medicatio n Erro r Rep o rt An alysis. Ho sp Pharm. 2 0 1 7 Jun ; 5 2 (6 ): 3 9 0 -3 9 3 . [PMC free article: PMC5 7 3 5 6 9 7 ] [PubMed: 2 9 2 7 6 2 6 0 ] Nucko ls TK, Smith-Sp an gler C, Mo rto n SC, Asch SM, Patel VM, An derso n LJ, Deichsel EL, Shekelle PG. The effectiven ess o f co mp uteriz ed o rder en try at reducin g p reven table adverse drug even ts an d medicatio n erro rs in ho sp ital settin gs: a systematic review an d meta-an alysis. Syst Rev. 2 0 1 4 Jun 0 4 ; 3 : 5 6 . [PMC free article: PMC4 0 9 6 4 9 9 ] [PubMed: 2 4 8 9 4 0 7 8 ] Bo n etti AF, Reis WC, Lo mbardi NF, Men des AM, Netto HP, Ro tta I, Fern an dez -Llimo s F, Po n taro lo R. Pharmacist-led discharge medicatio n co un sellin g: A sco p in g review. J Eval Clin Pract. 2 0 1 8 Jun ; 2 4 (3 ): 5 7 0 -5 7 9 . [PubMed: 2 9 6 9 1 9 5 5 ] Samaran ayake NR, Cheun g DS, Lam MP, Cheun g TT, Chui WC, Wo n g IC, Cheun g BM. The effectiven ess o f a 'Do No t Use' list an d p ercep tio n s o f healthcare p ro fessio n als o n erro r-p ro n e abbreviatio n s. In t J Clin Pharm. 2 0 1 4 Oct; 3 6 (5 ): 1 0 0 0 -6 . [PubMed: 2 5 0 9 8 9 4 6 ] Co rn uault L, Mo uchel V, Phan Thi TT, Beaussier H, Bé z ie Y, Co rn y J. Iden tificatio n o f variables in fluen cin g p harmaceutical in terven tio n s to imp ro ve medicatio n review efficien cy. In t J Clin Pharm. 2 0 1 8 Oct; 4 0 (5 ): 1 1 7 5 - 1 1 7 9 . [PubMed: 2 9 8 6 0 7 0 6 ] Chen g R, Yan g YD, Chan M, Patel T. Medicatio n In ciden ts In vo lvin g An tiep ilep tic Drugs in Can adian Ho sp itals: A Multi-In ciden t An alysis. Healthc Q. 2 0 1 7 ; 2 0 (2 ): 5 4 -6 2 . [PubMed: 2 8 8 3 7 0 1 6 ] Almeida TA, Reis EA, Pin to IVL, Ceccato MDGB, Silveira MR, Lima MG, Reis AMM. Facto rs asso ciated with the use o f p o ten tially in ap p ro p riate medicatio n s by o lder adults in p rimary health care: An an alysis co mp arin g AGS Beers, EU(7 )-PIM List , an d Braz ilian Co n sen sus PIM criteria. Res So cial Adm Pharm. 2 0 1 9 Ap r; 1 5 (4 ): 3 7 0 -3 7 7 . [PubMed: 2 9 9 3 4 2 7 7 ] Di Simo n e E, Gian n etta N, Auddin o F, Cico tto A, Grilli D, Di Muz io M. Medicatio n Erro rs in the Emergen cy Dep artmen t: Kn o wledge, Attitude, Behavio r, an d Train in g Needs o f Nurses. In dian J Crit Care Med. 2 0 1 8 May; 2 2 (5 ): 3 4 6 -3 5 2 . [PMC free article: PMC5 9 7 1 6 4 4 ] [PubMed: 2 9 9 1 0 5 4 5 ] Isaacs AN, Ch'n g K, Delhiwale N, Taylo r K, Ken t B, Raymo n d A. Ho sp ital medicatio n erro rs: a cro ss-sectio n al study. In t J Qual Health Care. 2 0 2 1 Feb 2 0 ; 3 3 (1 ) [PubMed: 3 3 0 6 4 7 9 7 ] Gillan i SW, Gulam SM, Tho mas D, Gebreighz iabher FB, Al-Sallo um J, Assadi RA, Sam KG. Ro le an d Services o f a Pharmacist in the Preven tio n o f Medicatio n Erro rs: A Systematic Review. Curr Drug Saf. 2 0 2 1 ; 1 6 (3 ): 3 2 2 - 3 2 8 . [PubMed: 3 3 0 0 6 5 3 9 ] Avery AJ, Sheehan C, Bell B, Armstro n g S, Ashcro ft DM, Bo yd MJ, Chuter A, Co o p er A, Do n n elly A, Edwards 4 1 . A, Evan s HP, Hellard S, Lymn J, Mehta R, Ro dgers S, Sheikh A, Smith P, Williams H, Camp bell SM, Carso n - Steven s A. In ciden ce, n ature an d causes o f avo idable sign ifican t harm in p rimary care in En glan d: retro sp ective case n o te review. BMJ Qual Saf. 2 0 2 1 Dec; 3 0 (1 2 ): 9 6 1 -9 7 6 . [PMC free article: PMC8 6 0 6 4 6 4 ] [PubMed: 3 3 1 7 2 9 0 7 ] Len z JR, Degn an DD, Hertig JB, Steven so n JG. A Review o f Best Practices fo r In traven o us Push Medicatio n Admin istratio n . J In fus Nurs. 2 0 1 7 No v/Dec; 4 0 (6 ): 3 5 4 -3 5 8 . [PubMed: 2 9 1 1 2 5 8 2 ] Copyright © 2022, StatPearls Publishing LLC. This book is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/) , which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author( s) and the source, a link is provided to the Creative Commons license, and any changes made are indicated. Bookshelf ID: NBK519065 PMID: 30085607","libVersion":"0.3.2","langs":""}